Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14673444 | 0.76 | ALDH1A1 (0.44) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL2026426 | 0.71 | ALDH1A1 (0.38) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| Methacrylic Acid SCHEMBL12803308 | 0.69 | ALDH1A1 (0.44) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL332874 | 0.69 | EPHX2 (0.43) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL9244526 | 0.67 | EPHX2 (0.47) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL23495517 | 0.67 | NPC1 (0.32) | ALDH1A1NPC1 | |
| Adamantane SCHEMBL17666824 | 0.66 | TSHR (0.35) | EPHX2ALDH1A1NPC1SMN1; SMN2MAPT | |
| SCHEMBL3674042 | 0.65 | ALDH1A1 (0.43) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL1089252 | 0.64 | ALDH1A1 (0.50) | EPHX2ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL15149727 | 0.64 | ALDH1A1 (0.50) | EPHX2ALDH1A1NPC1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2539316-B1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2019-10-23 | — | — | EP | disclosed |
| US-8580478-B2 | Latent acids and their use | BASF SE (DE) | 2013-11-12 | — | — | US | disclosed |
| EP-2539316-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2013-01-02 | — | — | EP | disclosed |
| US-20110217654-A1 | Latent acids and their use | BASF SE (DE) | 2011-09-08 | — | — | US | disclosed |
| WO-2011104127-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2011-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110217654-A1 | Latent acids and their use | NR1H3, NR1H2, NR2E3 | EPHX2 860/4885ALDH1A1 1395/4885NPC1 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.